6 results on '"Pedro Machado Medeiros de Albuquerque"'
Search Results
2. Prediction of Novel Drug Targets and Vaccine Candidates against Human Lice (Insecta), Acari (Arachnida), and Their Associated Pathogens
- Author
-
Abid Ali, Shabir Ahmad, Pedro Machado Medeiros de Albuquerque, Atif Kamil, Fahdah Ayed Alshammari, Abdulaziz Alouffi, and Itabajara da Silva Vaz
- Subjects
lice ,acari ,essential gene ,drug targets ,vaccine candidates ,subtractive analysis ,Medicine - Abstract
The emergence of drug-resistant lice, acari, and their associated pathogens (APs) is associated with economic losses; thus, it is essential to find new appropriate therapeutic approaches. In the present study, a subtractive proteomics approach was used to predict suitable therapeutics against these vectors and their infectious agents. We found 9701 proteins in the lice (Pediculus humanus var. corporis) and acari (Ixodes scapularis, Leptotrombidium deliense), and 4822 proteins in the proteomes of their APs (Babesia microti, Borreliella mayonii, Borrelia miyamotoi, Borrelia recurrentis, Rickettsia prowazekii, Orientia tsutsugamushi str. Boryong) that were non-homologous to host proteins. Among these non-homologous proteins, 365 proteins of lice and acari, and 630 proteins of APs, were predicted as essential proteins. Twelve unique essential proteins were predicted to be involved in four unique metabolic pathways of lice and acari, and 103 unique proteins were found to be involved in 75 unique metabolic pathways of APs. The sub cellular localization analysis of 115 unique essential proteins of lice and acari and their APs revealed that 61 proteins were cytoplasmic, 42 as membrane-bound proteins and 12 proteins with multiple localization. The druggability analysis of the identified 73 cytoplasmic and multiple localization essential proteins revealed 22 druggable targets and 51 novel drug targets that participate in unique pathways of lice and acari and their APs. Further, the predicted 42 membrane bound proteins could be potential vaccine candidates. Screening of useful inhibitors against these novel targets may result in finding novel compounds efficient for the control of these parasites.
- Published
- 2021
- Full Text
- View/download PDF
3. Expression cassette and plasmid construction for Yeast Surface Display in Saccharomyces cerevisiae
- Author
-
Fábio Pereira Leivas Leite, Vitória Sequeira Gonçalves, Neida Lucia Conrad, Rodrigo Casquero Cunha, Pedro Machado Medeiros de Albuquerque, Alceu Gonçalves dos Santos Junior, and Renan Eugênio Araujo Piraine
- Subjects
0106 biological sciences ,0301 basic medicine ,Signal peptide ,Recombinant Fusion Proteins ,Saccharomyces cerevisiae ,Dot blot ,Bioengineering ,01 natural sciences ,Applied Microbiology and Biotechnology ,law.invention ,Mice ,03 medical and health sciences ,Plasmid ,Viral Envelope Proteins ,law ,010608 biotechnology ,Animals ,biology ,Chemistry ,General Medicine ,biology.organism_classification ,Molecular biology ,Yeast ,030104 developmental biology ,Polyclonal antibodies ,Recombinant DNA ,biology.protein ,Expression cassette ,Cell Surface Display Techniques ,Plasmids ,Biotechnology - Abstract
Develop a Cell Surface Display system in Saccharomyces cerevisiae, based on the construction of an expression cassette for pYES2 plasmid. The construction of an expression cassette containing the α-factor signal peptide and the C-terminal portion of the α-agglutinin protein was made and its sequence inserted into a plasmid named pYES2/gDαAgglutinin. The construction allows surface display of bovine herpesvirus type 5 (BoHV-5) glycoprotein D (gD) on S. cerevisiae BY4741 strain. Recombinant protein expression was confirmed by dot blot, and indirect immunofluorescence using monoclonal anti-histidine antibodies and polyclonal antibodies from mice experimentally vaccinated with a recombinant gD. These results demonstrate that the approach and plasmid used represent not only an effective system for immobilizing proteins on the yeast cell surface, as well as a platform for immunobiologicals development.
- Published
- 2021
4. [Expression and characterization of equid herpesvirus 1 glycoprotein D in Pichia pastoris]
- Author
-
Paulo Ricardo Centeno Rodrigues, Vitória Sequeira Gonçalves, Fábio Pereira Leivas Leite, Francisco Denis Souza Santos, A. G Santos Júnior, Marcelo de Lima, Rodrigo Casquero Cunha, and Pedro Machado Medeiros de Albuquerque
- Subjects
0106 biological sciences ,0303 health sciences ,General Veterinary ,biology ,viral diseases ,biology.organism_classification ,01 natural sciences ,Molecular biology ,SF1-1100 ,doenças víricas ,recombinant proteins ,Epitope ,equines ,Animal culture ,03 medical and health sciences ,equinos ,010608 biotechnology ,biology.protein ,proteínas recombinantes ,Antibody ,030304 developmental biology ,Pichia ,Viral antigens - Abstract
RESUMO O herpesvírus equídeo 1 (EHV-1) apresenta distribuição mundial e causa graves prejuízos à equideocultura. É agente de surtos de doença respiratória, reprodutiva e neurológica, em equídeos jovens e adultos. A glicoproteína D (gD) do envelope viral é essencial para ligação e penetração em células permissivas e direcionamento do sistema imunológico do hospedeiro, induz respostas imunes humorais e celulares, sendo um antígeno apropriado para ser utilizado em vacinas e imunodiagnóstico. O objetivo deste trabalho foi expressar e caracterizar a gD do EHV-1 em Pichia pastoris para posterior utilização como antígeno em técnicas de imunodiagnóstico e formulação de vacinas recombinantes. Uma sequência de DNA que codifica uma forma truncada da gDEHV-1 foi clonada no vetor pPICZαA de expressão em P. pastoris. Obteve-se uma proteína de ~41 kDa, como esperado. A proteína apresentou glicosilação entre 4 kDa e 16 kDa, demonstrada por deglicosilação enzimática. A proteína recombinante foi caracterizada antigenicamente e imunogenicamente por Western blot, utilizando-se anticorpos policlonais equinos anti-EHV-1, e por ELISA indireto em modelo murino, demonstrando que a gD recombinante manteve epítopos similares aos da proteína nativa. Esses resultados sugerem que a gDEHV-1 é um antígeno promissor para uso como imunobiológico no controle do EHV-1. ABSTRACT Equine herpesvirus 1 (EHV-1) has a worldwide distribution and causes serious damage to horse breeding. It is an agent of respiratory, reproductive and neurological disease outbreaks in young and adult equids. Viral envelope glycoprotein D (gD) is essential for binding and penetration into permissive cells and targeting the host immune system, inducing humoral and cellular immune responses, and is an appropriate antigen for use in vaccines and immunodiagnostics. The objective of this work was to express in Pichia pastoris and to characterize EHV-1 gD for later use as an antigen in immunodiagnostic techniques and formulation of recombinant vaccines. A DNA sequence encoding a truncated form of gDEHV-1 has been cloned into the P. pastoris expression vector pPICZαA. A protein of ~41 kDa was obtained as expected. The protein presented glycosylation between 4 kDa and 16 kDa, demonstrated by enzymatic deglycosylation. The recombinant protein was antigenically and immunogenically characterized by Western blot using equine polyclonal anti-EHV-1 antibodies, and by indirect ELISA in a murine model, demonstrating that the recombinant gD maintained epitopes similar to those of the native protein. These results suggest that gDEHV-1 is a promising antigen for use as an immunobiological in the control of EHV-1.
- Published
- 2020
5. Immunocontraceptive potential of a recombinant chimeric protein composed by a single gonadotropin-releasing hormone molecule and B subunit of Escherichia coli heat-labile enterotoxin in a mice model
- Author
-
Neida Lucia Conrad, Lívia Budziarek Eslabão, Carine Dahl Corcini, Fábio Pereira Leivas Leite, Rodrigo Casquero Cunha, Pedro Machado Medeiros de Albuquerque, and Renan Eugênio Araujo Piraine
- Subjects
Biochemistry ,Chemistry ,law ,Protein subunit ,medicine ,Recombinant DNA ,Molecule ,Gonadotropin-releasing hormone ,Heat-labile enterotoxin ,medicine.disease_cause ,Escherichia coli ,Fusion protein ,law.invention - Published
- 2020
6. USE OF PROTEIN DIETS AS A SUPPLEMENT FOR AFRICANIZED BEES Apis mellifera
- Author
-
Beatriz Veleirinho, Vitória Sequeira Gonçalves, Vinicius Farias Campos, Mara Rúbia Romeu Pinto, Rodrigo Casquero Cunha, Pedro Machado Medeiros de Albuquerque, Marcelo Maraschin, and Fábio Pereira Leivas Leite
- Subjects
fungi ,food and beverages ,General Medicine - Abstract
At the nature, bees consume pollen and nectar to obtain its nutrients (proteins, lipids, carbohydrates, vitamins, and minerals). Changes in bee pastures have occurred as green areas and forests have been replaced by agricultural areas affecting colony health and productivity. Because of this, the efficiency of artificial protein diets for the Africanized honey bee (Apis mellifera, L.) was evaluated - considering the total protein content of the hemolymph, weight of the bees, and dietary consumption. The crude protein of the diets ranged from 12.2 to 24.4%. Newly emerged workers were caged and kept in an incubator with controlled temperature and humidity until six days old, receiving diets and water ad libitum. Hemolymph was collected from 0- and 6-day-old workers. Comparing the diets, significant differences in the protein content in the hemolymph, bee weight, and diet consumption were found among the treatments. A diet composed of 20% sugarcane yeast, 20% textured soy protein, and 60% sucrose was the most efficient according to measures of total protein in the hemolymph, bee weight and diet consumption. The use of protein sources as a supplement for hives can be a safe and viable alternative for beekeepers.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.